Online citations, reference lists, and bibliographies.
← Back to Search

Significant Improvement Of Stiff‐person Syndrome After Paraspinal Injection Of Botulinum Toxin A

D. Davis, B. Jabbari
Published 1993 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Following several months of low back pain, a 36‐year‐old developed progressive stiffness of the abdominal, low back, and thigh muscles. On examination, these muscles demonstrated marked hypertonia consistent with the clinical diagnosis of stiff‐person syndrome. The patient demonstrated increased lumbar lordosis and had focal hyperhidrosis at different sites. Electromyography showed continuous activity of the paraspinal and thigh muscles, and serum and cerebrospinal fluid antibodies to glutamic acid decarboxylase (GAD) were markedly elevated. Diazepam and Lioresal offered partial pain relief. Paraspinal muscle administration of botulinum toxin A reduced the tone of paraspinal and thigh muscles significantly and resulted in marked improvement of ambulation and cessation of pain.
This paper references
10.1016/0002-9343(67)90057-5
A critical survey of stiff-man syndrome.
E. E. Gordon (1967)
10.1002/ANA.410090516
Baclofen in the treatment of staff‐man syndrome
F. R. Miller (1981)
10.1001/ARCHNEUR.1980.00500580096024
Baclofen in treatment of the 'stiff-man' syndrome.
J. L. Whelan (1980)
10.1016/0166-2236(91)90044-U
Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus
M. Solimena (1991)
10.1056/NEJM198804213181602
Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.
M. Solimena (1988)
10.1002/ANA.410260118
Stiff‐Man syndrome, dysimmune disorder, and cancer
G. Piccola (1989)
10.1212/WNL.31.9.1162
Improvement Of stiff‐man syndrome with sodium valproate
R. Spehlmann (1981)
10.1056/NEJM198906013202220
Plasmapheresis in the treatment of stiff-man syndrome.
A. Vicari (1989)
10.1016/S0025-6196(12)65157-X
Clinical neurophysiologic studies in stiff-man syndrome: use of simultaneous video-electroencephalographic-surface electromyographic recording.
C. Armon (1990)
10.1212/WNL.41.10.1588
Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff‐man syndrome
H. R. Brashear (1991)
10.1073/PNAS.88.19.8337
Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10.
A. E. Karlsen (1991)
10.1212/WNL.25.7.622
A pharmacologic study of the stiff‐man syndrome
R. Schmidt (1975)
10.1136/jnnp.53.8.695
Stiffman syndrome: a rare paraneoplastic disorder?
D. Bateman (1990)
10.1001/JAMA.1977.03270450020010
Stiff-man syndrome and clonazepam.
U. Westblom (1977)
10.1038/347151A0
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
S. Baekkeskov (1990)
10.1001/ARCHNEUR.1980.00500520080018
Stiff-man syndrome with abnormalities in CSF and computerized tomography findings. Report of a case.
E. Maida (1980)
10.1002/ANA.410190518
Antimigraine drug interactions with 5‐hydroxytryptamine1A receptors
B. Hiner (1986)
10.1016/S0025-6196(12)61012-X
Stiff-man syndrome.
K. McEvoy (1991)
10.1136/jnnp.47.3.280
The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine.
H. Meinck (1984)
10.1056/NEJM199005313222202
Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome.
M. Solimena (1990)
10.1056/NEJM198804213181610
Stiff-man syndrome--an autoimmune disease?
R. Layzer (1988)
10.1002/ANA.410280407
Treatment of spasticity with botulinum toxin: A double‐blind study
B. Snow (1990)
10.1002/MDS.870060104
Stiff‐person syndrome: An autoimmune disease
Peter W. Blum (1991)
10.1016/S0025-6196(12)65339-7
Stiff-man syndrome updated.
T. R. Lorish (1989)



This paper is referenced by
A stiff-person-szindrómáról két eset kapcsán
Kemény Zsuzsanna (2013)
10.1016/j.jns.2019.06.021
SPS: Understanding the complexity
Rima El-Abassi (2019)
10.1159/000008152
Continuous Facial Myokymia in Multiple Sclerosis: Treatment with Botulinum Toxin
M. J. Sedano (2000)
10.1007/s00482-003-0203-4
Botulinum-Toxin in der speziellen Schmerztherapie
H. Goebel (2003)
10.1016/B978-0-444-52137-8.00012-7
Chapter 12 – Spasticity
V. Dietz (2012)
10.1007/978-3-030-43059-7_12
Treatment of Stiff-Person Spectrum Disorders
P. Termsarasab (2020)
10.1136/JNNP.71.4.564
Response to botulinum toxin in a case of rigid spine syndrome
J. Sastre-Garriga (2001)
10.1155/2019/9317916
Utility of Botulinum Injections in Stiff-Person Syndrome
L. M. Conners (2019)
10.12968/IJTR.2004.11.5.13341
Efficacy of botulinum toxin for spasticity management in neurorehabilitation
J. Kulkarni (2004)
10.1016/B978-1-4377-0372-6.00017-7
17 – Treatment and Management of Disorders of Neuromuscular Hyperexcitability
P. Narayanaswami (2011)
10.1097/01.NPT.0000282147.18446.b8
Physical Therapy During In‐Patient Rehabilitation for a Patient with Stiff‐Person Syndrome
K. Potter (2006)
10.1016/j.tox.2013.02.006
Botulinum toxins: mechanisms of action, antinociception and clinical applications.
A. Wheeler (2013)
10.1159/000069640
Botulinum Toxin in Low Back Pain
W. Jost (2003)
10.1016/S0306-9877(98)90053-6
A re-evaluation of the mechanism of action of botulinum toxin on facial movement disorders in man.
F. E. Leon-S. (1998)
10.1007/978-3-030-19515-1_20
Stiff-Person Syndrome Spectrum Disorders
J. Baizabal-Carvallo (2019)
10.1136/pgmj.74.877.642
Amiodarone-induced cornea verticillata.
D. Goldblum (1998)
10.1002/mds.1152
Focal myopathy as a cause of anterocollis in Parkinsonism
N. Lava (2001)
10.1016/S1169-8330(03)00324-7
Place de la toxine botulique dans les rachialgies de l’IMC adulte. À propos d’une observation
P. Gallien (2004)
10.1212/WNL.56.10.1290
Botulinum toxin A and chronic low back pain
L. Foster (2001)
10.1136/jnnp-2014-309201
Stiff-person syndrome: insights into a complex autoimmune disorder
J. Baizabal-Carvallo (2014)
10.1016/J.JBSPIN.2006.03.005
New indications for botulinum toxin in rheumatology.
G. Monnier (2006)
10.1016/S1297-319X(03)00124-6
Role for botulinum toxin in back pain treatment in adults with cerebral palsy: report of a case.
P. Gallien (2004)
10.1054/jocn.2000.0684
The current use of botulinum toxin
N. Mahant (2000)
10.1136/pgmj.74.877.641
Stiff-man syndrome.
H. Rehman (1998)
10.1016/J.RHUM.2006.03.018
Les indications de la toxine botulinique en rhumatologie
G. Monnier (2006)
10.1007/978-3-642-85173-5_6
Clinical use of botulinum neurotoxins.
F. Cardoso (1995)
Stiff-person syndrome-- DEEPER lOOK
(2011)
10.1016/B978-012125831-3/50282-3
The Syndrome of Spastic Paresis
V. Dietz (2003)
10.1002/mus.23416
Botulinum toxin A in anti–gad‐positive stiff‐limb syndrome
E. Anagnostou (2012)
10.1007/978-3-030-43059-7
Stiff-Person Syndrome and Related Disorders: A Comprehensive, Practical Guide
P. Termsarasab (2020)
10.1556/OH.2013.29773
[The stiff-person syndrome: a brief review and report of two cases].
Zsuzsanna Kemény (2013)
10.1002/mus.20653
Rigidity and spasms from autoimmune encephalomyelopathies: Stiff‐person syndrome
A. Espay (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar